Takayuki Motoki

Okayama University — Japan

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index870citations61works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(14), Gastrointestinal Tumor Research and Treatment(11), HER2/EGFR in Cancer Research(10), Esophageal Cancer Research and Treatment(6), Breast Lesions and Carcinomas(6)

Publications61 total

Supplementary Table S1 from Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
2023Open Access
Data from Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
2023Open Access
Supplementary Table S2 from Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
2023Open Access
Data from Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
2023Open Access
Data from Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma <i>In vitro</i> and <i>In vivo</i>
2023Open Access
Supplementary Table 1 from Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma <i>In vitro</i> and <i>In vivo</i>
2023Open Access
Supplementary Table S1 from Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
2023Open Access
Data from Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma <i>In vitro</i> and <i>In vivo</i>
2023Open Access
Supplementary Table 1 from Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma <i>In vitro</i> and <i>In vivo</i>
2023Open Access
Supplementary Table S2 from Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
2023Open Access
Safety and Efficacy of a Well-Fitting Brassiere after Breast Reconstruction: A Qualitative Study.
PubMed·2023· 1 citedOpen Access
A Multicenter Study of Docetaxel at a Dose of 100 mg/m<sup>2</sup> in Japanese Patients with Advanced or Recurrent Breast Cancer
Internal Medicine·2020· 6 citedOpen Access
Metaplastic carcinoma of the breast : Two cases
Okayama Igakkai Zasshi (Journal of Okayama Medical Association)·2018Open Access
A Case of Psoriasis Complicated by Breast Cancer after Systemic Treatments Including Biologics.
PubMed·2018· 4 cited
Sorafenib treatment for papillary thyroid carcinoma with diffuse lung metastases in a child with autism spectrum disorder: a case report
BMC Cancer·2017· 8 citedOpen Access
Tumour-infiltrating lymphocytes (TILs)-related genomic signature predicts chemotherapy response in breast cancer
Breast Cancer Research and Treatment·2017· 36 cited
Immunohistochemical Ki67 after short-term hormone therapy identifies low-risk breast cancers as reliably as genomic markers
Oncotarget·2017· 19 citedOpen Access
A Phase I Trial of 100 mg/m2 Docetaxel in Patients with Advanced or Recurrent Breast Cancer.
PubMed·2016· 2 cited
A phase 1, dose-finding and pharmacokinetic study of gemcitabine with nab-paclitaxel in patients with metastatic breast cancer
Cancer Chemotherapy and Pharmacology·2016· 8 cited
Development of a Japanese version of the BREAST-Q and the traditional psychometric test of the mastectomy module for the assessment of HRQOL and patient satisfaction following breast surgery
Breast Cancer·2016· 34 cited
page 1 of 4Next →

Frequent Co-authors

Junji Matsuoka(37), Yoshio Naomoto(26), Yasuhiro Shirakawa(25), Tomoki Yamatsuji(22), Noriaki Tanaka(20), Munenori Takaoka(20), Minoru Haisa(18), Takayuki Iwamoto(17), Hiroyoshi Doihara(15), Kazufumi Sakurama(15), Tadahiko Shien(14), Naruto Taira(14), Tomohiro Nogami(13), Kazuhiro Noma(13), Yasuko Tomono(11), Taeko Mizoo(10), Toshiyoshi Fujiwara(8), Shinji Hatakeyama(8), Osamu Ohmori(8), Tetsuji Nobuhisa(6)